Finance

Beta
Lists
AGMB:NASDAQ
Agomab Therapeutics NV
$11.25
-2.51%
(-0.29) 1D
May 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AGMB...
Open
$11.38
High
$11.55
Low
$11.05
Mkt. cap
554.04M
Avg. vol.
108.56K
Volume
17.44K
52-wk high
$17.45
52-wk low
$9.00
EPS
-$1.50
No. of employees
62
Open
$11.38
High
$11.55
Low
$11.05
Mkt. cap
554.04M
Avg. vol.
108.56K
Volume
17.44K
52-wk high
$17.45
52-wk low
$9.00
EPS
-$1.50
No. of employees
62
News stories
From sources across the web
About Agomab Therapeutics NV
CEO-
Employees62
Founded2017
Headquarters-
SectorPharmaceutical industry
Websiteagomab.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Dec 2024
Dec 2025
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
10.73M
13.86M
Total research and development expenses
-
-
Selling, general, and admin expenses
1.47M
3.17M
Operating expense
11.81M
16.53M
Total operating expenses
11.81M
16.53M
Operating income
-11.81M
-16.53M
Other non operating income
-309.00K
-1.54M
EBT including unusual items
-11.73M
-17.40M
EBT excluding unusual items
-11.73M
-17.40M
Income tax expense
4.00K
-
Effective tax rate
-0.03%
-
Other operating expenses
-383.00K
-506.00K
Net income
-11.73M
-17.40M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
626.00K
720.00K
Interest expense
-
-
Net interest expenses
626.00K
720.00K
Depreciation and amortization charges
-
-
EBITDA
-11.80M
-16.51M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer